Skip to Content

ETH 383 (Carbidopa and Levodopa Extended Release 50 mg / 200 mg)

Pill with imprint ETH 383 is Orange, Elliptical / Oval and has been identified as Carbidopa and Levodopa Extended Release 50 mg / 200 mg. It is supplied by Ethex Corporation.

Carbidopa/levodopa is used in the treatment of parkinson's disease; restless legs syndrome; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 50 mg / 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for ETH 383

Carbidopa and Levodopa Extended Release

Imprint:
ETH 383
Strength:
50 mg / 200 mg
Color:
Orange
Size:
13.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Ethex Corporation
Inactive Ingredients:
silicon dioxide colloidal
D&C Yellow No. 10
FD&C Red No. 3
fumaric acid
hypromellose
sodium stearyl fumarate
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide